对复合血小板因子4与原胺进行随机试验,以逆转人类氨酸抗凝作用

G J Dehmer1, R A Lange, D A Tate

  • 1Cardiac Catheterization Laboratories, University of North Carolina Hospitals, Chapel Hill 27514, USA.

Circulation
|November 1, 1996
PubMed
概括

再组合血小板因子4 (rPF4) 有效地逆转了肝素抗凝作用,没有显著的副作用,显示出作为心脏手术中蛋白质胺更安全的替代品的前景.

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...